Breaking News Instant updates and real-time market news.

TCON

Tracon Pharmaceuticals

$5.29 /

+0.76 (+16.78%)

06:29
09/17/20
09/17
06:29
09/17/20
06:29

Tracon Pharmaceuticals price target raised to $7 from $4 at H.C. Wainwright

H.C. Wainwright analyst Edward White raised the firm's price target on Tracon Pharmaceuticals to $7 from $4 and reiterates a Buy rating on the shares following the company's conference presentation. The analyst continues to project that envafolimab will reach the market in 2024 and have sales of $103M in 2028.

TCON Tracon Pharmaceuticals
$5.29 /

+0.76 (+16.78%)

04/24/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $4 from $6 at H.C. Wainwright
03/10/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $6 from $13 at H.C. Wainwright
02/28/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $13 from $18 at H.C. Wainwright
12/23/19 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $18 from $15 at H.C. Wainwright

TODAY'S FREE FLY STORIES

Upgrade
Elior upgraded to Buy on 'significant discount' at Berenberg » 06:42
09/18/20
09/18
06:42
09/18/20
06:42
ELROF

Elior Group

/

+

Berenberg analyst Annabel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ELROF Elior Group
/

+

05:05 Today Berenberg
Elior Group upgraded to Buy from Hold at Berenberg
08/17/20 Berenberg
Elior Group price target lowered to EUR 5.50 from EUR 6 at Berenberg
08/12/20 UBS
Elior Group price target raised to EUR 6 from EUR 5.80 at UBS
07/06/20 Bryan Garnier
Elior Group downgraded to Sell from Neutral at Bryan Garnier
Upgrade
Morgan Stanley ups SunPower to Equal Weight after manufacturing unit spinoff » 06:42
09/18/20
09/18
06:42
09/18/20
06:42
SPWR

SunPower

$9.90 /

-0.8 (-7.48%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPWR SunPower
$9.90 /

-0.8 (-7.48%)

SPWR SunPower
$9.90 /

-0.8 (-7.48%)

05:07 Today Morgan Stanley
SunPower upgraded to Equal Weight from Underweight at Morgan Stanley
09/11/20 Baird
Baird upgrades 'simpler' SunPower to Outperform with $13 target
09/11/20 Baird
SunPower upgraded to Outperform from Neutral at Baird
07/14/20 Spin-Off Research
SunPower downgraded to Sell from Hold at Spin-Off Research
SPWR SunPower
$9.90 /

-0.8 (-7.48%)

  • 21
    Nov
SPWR SunPower
$9.90 /

-0.8 (-7.48%)

SPWR SunPower
$9.90 /

-0.8 (-7.48%)

Hot Stocks
AstraZeneca reports Lynparza PFS benefit vs. placebo during ESMO presentation » 06:42
09/18/20
09/18
06:42
09/18/20
06:42
AZN

AstraZeneca

$55.93 /

+0.79 (+1.43%)

, MRK

Merck

$85.65 /

+0.01 (+0.01%)

AstraZeneca (AZN) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 SVB Leerink
AstraZeneca COVID vaccine hold may cause ripple, says SVB Leerink
09/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts 'underappreciated' Entasis at Overweight
MRK Merck
$85.65 /

+0.01 (+0.01%)

09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
08/11/20 H.C. Wainwright
Pfenex acquisition fits well with Ligand growing portfolio, says H.C. Wainwright
AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

Hot Stocks
Alkermes presents ARTISTRY-1 data, expands monotherapy melanoma cohort » 06:41
09/18/20
09/18
06:41
09/18/20
06:41
ALKS

Alkermes

$18.45 /

+0.57 (+3.19%)

Alkermes said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALKS Alkermes
$18.45 /

+0.57 (+3.19%)

ALKS Alkermes
$18.45 /

+0.57 (+3.19%)

08/21/20 Mizuho
Alkermes comments on FDA panel may pressure shares, says Mizuho
07/30/20 Mizuho
Alkermes price target raised to $19 from $16 at Mizuho
07/30/20 Goldman Sachs
Alkermes downgraded to Sell from Neutral at Goldman Sachs
06/19/20 Piper Sandler
Biogen price target lowered to $260 from $307 at Piper Sandler
ALKS Alkermes
$18.45 /

+0.57 (+3.19%)

Upgrade
CIBC upgrades Winpak to Outperformer on muted COVID impact » 06:40
09/18/20
09/18
06:40
09/18/20
06:40
WIPKF

Winpak

$0.00 /

+ (+0.00%)

CIBC analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WIPKF Winpak
$0.00 /

+ (+0.00%)

05:16 Today CIBC
Winpak upgraded to Outperformer from Neutral at CIBC
05/06/20 TD Securities
Winpak price target raised to C$48 from C$45 at TD Securities
05/06/20 Scotiabank
Winpak price target raised to C$53 from C$51 at Scotiabank
05/06/20 RBC Capital
Winpak price target lowered to C$45 from C$46 at RBC Capital
Downgrade
Novocure downgraded to Equal Weight at Wells Fargo on valuation » 06:37
09/18/20
09/18
06:37
09/18/20
06:37
NVCR

Novocure

$108.96 /

+1.71 (+1.59%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVCR Novocure
$108.96 /

+1.71 (+1.59%)

NVCR Novocure
$108.96 /

+1.71 (+1.59%)

05:18 Today Wells Fargo
Novocure downgraded to Equal Weight from Overweight at Wells Fargo
09/17/20
Fly Intel: Top five analyst downgrades
09/17/20 Truist
Novocure downgraded to Hold from Buy at Truist
09/17/20 Truist
Novocure downgraded to Hold from Buy at Truist
NVCR Novocure
$108.96 /

+1.71 (+1.59%)

NVCR Novocure
$108.96 /

+1.71 (+1.59%)

Upgrade
Fox Factory upgraded to Buy following pullback at Stifel » 06:36
09/18/20
09/18
06:36
09/18/20
06:36
FOXF

Fox Factory

$75.56 /

+2.36 (+3.22%)

, F

Ford

$7.29 /

+0.26 (+3.70%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOXF Fox Factory
$75.56 /

+2.36 (+3.22%)

F Ford
$7.29 /

+0.26 (+3.70%)

FOXF Fox Factory
$75.56 /

+2.36 (+3.22%)

09/17/20 Stifel
Fox Factory upgraded to Buy from Hold at Stifel
07/15/20 Jefferies
Jefferies says Fox Factory absence on Bronco doesn't impair competitive position
07/14/20 Baird
Fox Factory down on Ford picking Bilstein for Bronco shocks, says Baird
06/16/20 CJS Securities
Fox Factory downgraded to Market Perform from Outperform at CJS Securities
F Ford
$7.29 /

+0.26 (+3.70%)

09/08/20
Fly Intel: Top five analyst upgrades
09/08/20 Evercore ISI
Evercore ISI giving Ford 'benefit of the doubt,' upgrades to In Line
09/08/20 Evercore ISI
Ford upgraded to In Line from Underperform at Evercore ISI
08/17/20 Credit Suisse
Credit Suisse say Ford, GM can fund EV development through strong trucking
FOXF Fox Factory
$75.56 /

+2.36 (+3.22%)

F Ford
$7.29 /

+0.26 (+3.70%)

  • 18
    Jun
F Ford
$7.29 /

+0.26 (+3.70%)

FOXF Fox Factory
$75.56 /

+2.36 (+3.22%)

F Ford
$7.29 /

+0.26 (+3.70%)

F Ford
$7.29 /

+0.26 (+3.70%)

Recommendations
Quanta Services price target raised to $60 from $45 at KeyBanc » 06:35
09/18/20
09/18
06:35
09/18/20
06:35
PWR

Quanta Services

$52.62 /

+0.095 (+0.18%)

KeyBanc analyst Sean…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PWR Quanta Services
$52.62 /

+0.095 (+0.18%)

PWR Quanta Services
$52.62 /

+0.095 (+0.18%)

08/07/20 Citi
Quanta Services price target raised to $55 from $50 at Citi
07/17/20 B. Riley FBR
Quanta Services price target raised to $47 from $42 at B. Riley FBR
07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
06/23/20 Stifel
Quanta Services price target raised to $50 from $46 at Stifel
PWR Quanta Services
$52.62 /

+0.095 (+0.18%)

PWR Quanta Services
$52.62 /

+0.095 (+0.18%)

PWR Quanta Services
$52.62 /

+0.095 (+0.18%)

PWR Quanta Services
$52.62 /

+0.095 (+0.18%)

Hot Stocks
AstraZeneca presents updated Imfinzi results from PACIFIC trial at ESMO » 06:35
09/18/20
09/18
06:35
09/18/20
06:35
AZN

AstraZeneca

$55.93 /

+0.79 (+1.43%)

Updated results from the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 SVB Leerink
AstraZeneca COVID vaccine hold may cause ripple, says SVB Leerink
09/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts 'underappreciated' Entasis at Overweight
AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

Hot Stocks
Pivotal Investment Corp. II, XL Fleet enter definitive merger agreement » 06:35
09/18/20
09/18
06:35
09/18/20
06:35
PIC

Pivotal Investment Corp. II

$10.57 /

-0.03 (-0.28%)

XL Fleet and Pivotal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Nike price target raised to $132 from $118 at Barclays » 06:34
09/18/20
09/18
06:34
09/18/20
06:34
NKE

Nike

$116.36 /

-2.24 (-1.89%)

Barclays analyst Adrienne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$116.36 /

-2.24 (-1.89%)

NKE Nike
$116.36 /

-2.24 (-1.89%)

09/16/20 Piper Sandler
Nike price target raised to $130 from $112 at Piper Sandler
09/15/20 BTIG
Nike price target raised to $140 from $117 at BTIG
09/15/20 Deutsche Bank
Nike price target raised to $107 from $87 at Deutsche Bank
09/14/20 JPMorgan
Nike price target raised to $136 from $118 at JPMorgan
NKE Nike
$116.36 /

-2.24 (-1.89%)

NKE Nike
$116.36 /

-2.24 (-1.89%)

NKE Nike
$116.36 /

-2.24 (-1.89%)

NKE Nike
$116.36 /

-2.24 (-1.89%)

Upgrade
Stifel upgrades Dave & Buster's to Buy, calls pullback a chance to 'level up' » 06:33
09/18/20
09/18
06:33
09/18/20
06:33
PLAY

Dave & Buster's

$14.13 /

-4.99 (-26.10%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

04:47 Today Stifel
Dave & Buster's upgraded to Buy from Hold at Stifel
04:46 Today Raymond James
Dave & Buster's upgraded to Outperform from Market Perform at Raymond James
09/17/20 Truist
Truist says Dave & Buster's dip on 'unfounded' bankruptcy worries an opportunity
09/11/20 BMO Capital
Dave & Buster's price target raised to $17 from $15 at BMO Capital
PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

  • 04
    May
PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

Recommendations
Spirit Airlines price target raised to $24 from $18 at Barclays » 06:32
09/18/20
09/18
06:32
09/18/20
06:32
SAVE

Spirit Airlines

$18.10 /

-0.46 (-2.48%)

Barclays analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAVE Spirit Airlines
$18.10 /

-0.46 (-2.48%)

SAVE Spirit Airlines
$18.10 /

-0.46 (-2.48%)

07/09/20 Citi
Citi sees expectations for corporate travel rebound all but evaporating
06/29/20 Goldman Sachs
Spirit Airlines price target raised to $20 from $15 at Goldman Sachs
06/17/20
Fly Intel: Top five analyst initiations
06/17/20 Seaport Global
Spirit Airlines initiated with a Buy at Seaport Global
SAVE Spirit Airlines
$18.10 /

-0.46 (-2.48%)

  • 08
    May
SAVE Spirit Airlines
$18.10 /

-0.46 (-2.48%)

SAVE Spirit Airlines
$18.10 /

-0.46 (-2.48%)

SAVE Spirit Airlines
$18.10 /

-0.46 (-2.48%)

Recommendations
Southwest price target raised to $40 from $35 at Barclays » 06:31
09/18/20
09/18
06:31
09/18/20
06:31
LUV

Southwest

$40.39 /

-1.77 (-4.20%)

Barclays analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LUV Southwest
$40.39 /

-1.77 (-4.20%)

LUV Southwest
$40.39 /

-1.77 (-4.20%)

09/08/20 Morgan Stanley
Southwest initiated with an Overweight at Morgan Stanley
09/02/20
Fly Intel: Top five analyst upgrades
09/02/20 Berenberg
Berenberg ups Southwest to Buy, cuts American to Sell amid airline rating shift
09/02/20 Berenberg
Southwest upgraded to Buy from Hold at Berenberg
LUV Southwest
$40.39 /

-1.77 (-4.20%)

  • 29
    Apr
LUV Southwest
$40.39 /

-1.77 (-4.20%)

LUV Southwest
$40.39 /

-1.77 (-4.20%)

LUV Southwest
$40.39 /

-1.77 (-4.20%)

Hot Stocks
SpringsWorks Therapeutics enters research agreement with Fred Hutch » 06:31
09/18/20
09/18
06:31
09/18/20
06:31
SWTX

SpringsWorks Therapeutics

$46.48 /

-0.78 (-1.65%)

SpringWorks Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWTX SpringsWorks Therapeutics
$46.48 /

-0.78 (-1.65%)

SWTX SpringsWorks Therapeutics
$46.48 /

-0.78 (-1.65%)

09/15/20 Barclays
SpringsWorks Therapeutics price target raised to $55 from $52 at Barclays
06/02/20 Citi
Ayala Pharmaceuticals initiated with a Buy at Citi
05/05/20 Barclays
SpringsWorks Therapeutics initiated with an Overweight at Barclays
03/19/20 H.C. Wainwright
SpringsWorks Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
SWTX SpringsWorks Therapeutics
$46.48 /

-0.78 (-1.65%)

Recommendations
Delta Air Lines price target raised to $30 from $26 at Barclays » 06:31
09/18/20
09/18
06:31
09/18/20
06:31
DAL

Delta Air Lines

$33.94 /

-0.62 (-1.79%)

Barclays analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DAL Delta Air Lines
$33.94 /

-0.62 (-1.79%)

DAL Delta Air Lines
$33.94 /

-0.62 (-1.79%)

09/15/20 Seaport Global
Delta Air Lines initiated with a Buy at Seaport Global
09/08/20 Morgan Stanley
Delta Air Lines initiated with an Overweight at Morgan Stanley
09/02/20
Fly Intel: Top five analyst downgrades
09/02/20 Berenberg
Berenberg ups Southwest to Buy, cuts American to Sell amid airline rating shift
DAL Delta Air Lines
$33.94 /

-0.62 (-1.79%)

DAL Delta Air Lines
$33.94 /

-0.62 (-1.79%)

DAL Delta Air Lines
$33.94 /

-0.62 (-1.79%)

DAL Delta Air Lines
$33.94 /

-0.62 (-1.79%)

Recommendations
Allegiant Travel price target raised to $100 from $73 at Barclays » 06:31
09/18/20
09/18
06:31
09/18/20
06:31
ALGT

Allegiant Travel

$138.30 /

-4.08 (-2.87%)

Barclays analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALGT Allegiant Travel
$138.30 /

-4.08 (-2.87%)

ALGT Allegiant Travel
$138.30 /

-4.08 (-2.87%)

09/15/20 Seaport Global
Allegiant Travel initiated with a Buy at Seaport Global
09/09/20 Deutsche Bank
Allegiant Travel price target raised to $145 from $130 at Deutsche Bank
09/08/20 Morgan Stanley
Allegiant Travel initiated with an Overweight at Morgan Stanley
07/24/20 Wolfe Research
Allegiant Travel upgraded to Outperform from Peer Perform at Wolfe Research
ALGT Allegiant Travel
$138.30 /

-4.08 (-2.87%)

ALGT Allegiant Travel
$138.30 /

-4.08 (-2.87%)

ALGT Allegiant Travel
$138.30 /

-4.08 (-2.87%)

Recommendations
Alaska Air price target raised to $40 from $37 at Barclays » 06:30
09/18/20
09/18
06:30
09/18/20
06:30
ALK

Alaska Air

$42.15 /

-0.96 (-2.23%)

Barclays analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALK Alaska Air
$42.15 /

-0.96 (-2.23%)

ALK Alaska Air
$42.15 /

-0.96 (-2.23%)

09/15/20 Seaport Global
Alaska Air initiated with a Buy at Seaport Global
09/11/20 Wolfe Research
Alaska Air downgraded to Peer Perform from Outperform at Wolfe Research
09/08/20 Morgan Stanley
Alaska Air initiated with an Equal Weight at Morgan Stanley
07/09/20 Citi
Citi sees expectations for corporate travel rebound all but evaporating
ALK Alaska Air
$42.15 /

-0.96 (-2.23%)

ALK Alaska Air
$42.15 /

-0.96 (-2.23%)

ALK Alaska Air
$42.15 /

-0.96 (-2.23%)

ALK Alaska Air
$42.15 /

-0.96 (-2.23%)

Recommendations
Dollar General price target raised to $250 from $230 at JPMorgan » 06:28
09/18/20
09/18
06:28
09/18/20
06:28
DG

Dollar General

$203.42 /

+0.62 (+0.31%)

JPMorgan analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DG Dollar General
$203.42 /

+0.62 (+0.31%)

DG Dollar General
$203.42 /

+0.62 (+0.31%)

09/02/20 Argus
Argus raises earnings estimates for Dollar General after Q2 beat
08/31/20 KeyBanc
Dollar General price target raised to $225 from $210 at KeyBanc
08/28/20 BMO Capital
Dollar General price target raised to $223 from $200 at BMO Capital
08/28/20 JPMorgan
Dollar General price target raised to $230 from $220 at JPMorgan
DG Dollar General
$203.42 /

+0.62 (+0.31%)

DG Dollar General
$203.42 /

+0.62 (+0.31%)

DG Dollar General
$203.42 /

+0.62 (+0.31%)

DG Dollar General
$203.42 /

+0.62 (+0.31%)

Recommendations
Amazon.com's logistics network underappreciated by investors, says RBC Capital » 06:28
09/18/20
09/18
06:28
09/18/20
06:28
AMZN

Amazon.com

$3,010.11 /

-67.03 (-2.18%)

RBC Capital analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,010.11 /

-67.03 (-2.18%)

AMZN Amazon.com
$3,010.11 /

-67.03 (-2.18%)

09/16/20 Morgan Stanley
FedEx price target raised to $250 from $110 at Morgan Stanley
09/08/20 Goldman Sachs
Goldman sticks with Sell on Apple despite 71% rally since downgrade
09/03/20 Baird
Amazon working to better handle unprecedented seasonal Q4 demand, says Baird
09/03/20 Baird
Amazon.com meetings reinforce top pick status, says Baird
AMZN Amazon.com
$3,010.11 /

-67.03 (-2.18%)

AMZN Amazon.com
$3,010.11 /

-67.03 (-2.18%)

AMZN Amazon.com
$3,010.11 /

-67.03 (-2.18%)

AMZN Amazon.com
$3,010.11 /

-67.03 (-2.18%)

AMZN Amazon.com
$3,010.11 /

-67.03 (-2.18%)

Periodicals
Hertz told to revise plan for additional manager bonuses, WSJ reports » 06:28
09/18/20
09/18
06:28
09/18/20
06:28
HTZ

Hertz

$1.38 /

+0.045 (+3.37%)

A bankruptcy judge called…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HTZ Hertz
$1.38 /

+0.045 (+3.37%)

HTZ Hertz
$1.38 /

+0.045 (+3.37%)

08/20/20 Deutsche Bank
Hertz price target lowered to $2 from $3 at Deutsche Bank
06/24/20 Jefferies
CarMax, AutoNation could be eyeing Hertz in bankruptcy, says Jefferies
05/05/20 Morgan Stanley
2020 may not be quite as bad as feared for used cars, says Morgan Stanley
04/27/20
Fly Intel: Top five analyst downgrades
HTZ Hertz
$1.38 /

+0.045 (+3.37%)

HTZ Hertz
$1.38 /

+0.045 (+3.37%)

HTZ Hertz
$1.38 /

+0.045 (+3.37%)

HTZ Hertz
$1.38 /

+0.045 (+3.37%)

Recommendations
Citi opens 'positive catalyst watch' on LafargeHolcim » 06:25
09/18/20
09/18
06:25
09/18/20
06:25
HCMLY

LafargeHolcim

$0.00 /

+ (+0.00%)

Citi analyst Ephrem Ravi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HCMLY LafargeHolcim
$0.00 /

+ (+0.00%)

09/11/20 UBS
LafargeHolcim price target raised to CHF 47 from CHF 44 at UBS
07/31/20 JPMorgan
LafargeHolcim price target raised to CHF 50 from CHF 44 at JPMorgan
07/31/20 Morgan Stanley
LafargeHolcim price target raised to CHF 57 from CHF 54 at Morgan Stanley
07/10/20 Barclays
LafargeHolcim price target raised to CHF 49 from CHF 44 at Barclays
Recommendations
Protagonist Therapeutics price target raised to $33 from $28 at H.C. Wainwright » 06:22
09/18/20
09/18
06:22
09/18/20
06:22
PTGX

Protagonist Therapeutics

$21.23 /

+0.06 (+0.28%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PTGX Protagonist Therapeutics
$21.23 /

+0.06 (+0.28%)

PTGX Protagonist Therapeutics
$21.23 /

+0.06 (+0.28%)

07/15/20 Jefferies
Protagonist Therapeutics initiated with a Buy at Jefferies
05/18/20 H.C. Wainwright
Protagonist Therapeutics price target raised to $28 from $23 at H.C. Wainwright
05/11/20 Nomura Instinet
Protagonist Therapeutics price target raised to $33 from $29 at Nomura Instinet
04/30/20 Nomura Instinet
Protagonist shares offer 'asymmetric potential upside,' says Nomura Instinet
PTGX Protagonist Therapeutics
$21.23 /

+0.06 (+0.28%)

  • 12
    May
PTGX Protagonist Therapeutics
$21.23 /

+0.06 (+0.28%)

Recommendations
Gilead price target raised to $86 from $82 at RBC Capital » 06:21
09/18/20
09/18
06:21
09/18/20
06:21
GILD

Gilead

$65.02 /

-0.62 (-0.94%)

RBC Capital analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$65.02 /

-0.62 (-0.94%)

GILD Gilead
$65.02 /

-0.62 (-0.94%)

04:57 Today Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 Maxim
Gilead upgraded to Buy at Maxim following Immunomedics deal
09/15/20 Maxim
Gilead upgraded to Buy from Hold at Maxim
09/15/20 RBC Capital
Gilead price target lowered to $82 from $84 at RBC Capital
GILD Gilead
$65.02 /

-0.62 (-0.94%)

GILD Gilead
$65.02 /

-0.62 (-0.94%)

GILD Gilead
$65.02 /

-0.62 (-0.94%)

GILD Gilead
$65.02 /

-0.62 (-0.94%)

Recommendations
Arena Pharmaceuticals price target raised to $120 from $83 at Citi » 06:20
09/18/20
09/18
06:20
09/18/20
06:20
ARNA

Arena Pharmaceuticals

$70.48 /

+0.57 (+0.82%)

Citi analyst Joel Beatty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARNA Arena Pharmaceuticals
$70.48 /

+0.57 (+0.82%)

ARNA Arena Pharmaceuticals
$70.48 /

+0.57 (+0.82%)

09/14/20 JPMorgan
Arena Pharmaceuticals resumed with an Overweight at JPMorgan
08/17/20 Guggenheim
Arena Pharmaceuticals price target raised to $115 from $95 at Guggenheim
08/06/20 SVB Leerink
Arena Pharmaceuticals price target raised to $91 from $73 at SVB Leerink
08/06/20 Wells Fargo
Arena Pharmaceuticals price target raised to $78 from $60 at Wells Fargo
ARNA Arena Pharmaceuticals
$70.48 /

+0.57 (+0.82%)

  • 28
    May
ARNA Arena Pharmaceuticals
$70.48 /

+0.57 (+0.82%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.